Significant association between income and survival after surgery for lung cancer

July 02, 2020

Patients with low income have a higher risk of death following surgery for lung cancer compared with patients with high income. The association remains even after taking prevalence of common comorbidities, and other factors that are known to influence the risk of death, into account. This is according to a study published in the journal Thorax by researchers at Karolinska Institutet in Sweden.

There are known survival differences in the general population that are related to differences in socioeconomic status. Moreover, the gap in life expectancy seems to be increasing and can to a large part be explained by differences in deaths from cardiovascular disease and cancers.

Swedish population-based studies have previously shown a link between educational level and lung cancer survival and a strong correlation between income and survival after cardiac surgery. This prompted the research group in this study to investigate a possible association between household disposable income and survival after surgery for lung cancer.

"Sweden has a tax-funded universal health care system granting citizens equal access to care, therefore, we hypothesized that household disposable income would not be associated with long-term survival following lung cancer surgery," says Erik Sachs, PhD student at the Department of Molecular Medicine and Surgery at Karolinska Institutet, and resident in cardiothoracic surgery at the Karolinska University Hospital.

The researchers performed a population-based register study that included 5,500 patients who underwent surgery for lung cancer between 2008 and 2017. During a mean follow-up time of 3.2 years, 1,736 patients died.

After adjusting for a range of factors known to increase the risk of death, including old age, smoking and common comorbidities such as cardiovascular disease, the researchers found that patients in the highest income quintile had a 23 percent lower risk of death compared with patients in the lowest income quintile.

"Contrary to our hypothesis, the analysis showed that patients with low household disposable income had significantly worse long-term survival compared with patients with high household disposable income," says Erik Sachs, one of the study's authors. "We don't know what causes this association. To answer this question, studies investigating the underlying mechanisms of the association are needed."

The researchers note that they did not have access to information on diet, physical activity and social support, factors that have previously been associated with socioeconomic status and could potentially influence life expectancy.

"It is reasonable to assume that there are a number of factors that negatively affect lung cancer survival and whose effects would be possible to modify," says co-author Veronica Jackson, researcher at the Department of Molecular Medicine and Surgery at Karolinska Institutet and a cardiothoracic surgeon. "Our findings are important as they suggest that, with proper measures, it would likely be possible to improve the prognosis for patients with low household disposable income. But firstly, we have to identify which measures that are the "right" measures."
The study was financed with grants from the Swedish Heart-Lung Foundation, the Åke Wiberg Foundation, Karolinska Institutet Foundations and Funds, and the regional ALF agreement between Region Stockholm and Karolinska Institutet.

Publication: "Household disposable income and long-term survival after pulmonary resections for lung cancer", Erik Sachs, Veronica Jackson, and Ulrik Sartipy, Thorax, online June 20, 2020, doi: 10.1136/thoraxjnl-2019-214321

Karolinska Institutet

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to